| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.25 | 3e-07 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-05 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |